Atlas Trials

Biosplice Therapeutics, Inc.

22 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Biosplice Therapeutics, Inc.

RecordFirmDate
A Study Utilizing Patient-Reported Outcomes to Evaluate the Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (STRIDES) (NCT05603754)Biosplice Therapeutics, Inc.2022-11-18
A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid Tumors (NCT05084859)Biosplice Therapeutics, Inc.2021-11-03
3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis (NCT04931667)Biosplice Therapeutics, Inc.2021-07-15
Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers (NCT04598542)Biosplice Therapeutics, Inc.2020-10-13
A Long-Term Safety and Efficacy Study of Lorecivivint in Subjects With Osteoarthritis of the Knee (NCT04520607)Biosplice Therapeutics, Inc.2020-08-25
Patient-Reported and Radiographic Outcomes in Evaluating Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis (NCT03928184)Biosplice Therapeutics, Inc.2019-05-17
MRI Study to Evaluate the Safety and Efficacy of SM04690 for Knee Osteoarthritis (NCT03706521)Biosplice Therapeutics, Inc.2019-03-11
Safety and Bone Health Study of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis (NCT03727022)Biosplice Therapeutics, Inc.2018-11-28
A Study Evaluating the Efficacy and Safety of SM04554 Topical Solution in Male Subjects With Androgenetic Alopecia (NCT03742518)Biosplice Therapeutics, Inc.2018-11-01
A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors (NCT03355066)Biosplice Therapeutics, Inc.2017-11-06
A Repeat Insult Patch Test (RIPT) Study Evaluating the Sensitization Potential of Topical SM04755 Solution in Healthy Volunteers (NCT03502434)Biosplice Therapeutics, Inc.2017-09-11

Track Biosplice Therapeutics, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.